| 211096-49-0 Basic information More.. |
Product Name: | GSK-CXCR2 | Synonyms: | GSK-CXCR2;N-(2-Bromophenyl)-N'-(7-cyano-1H-benzotriazol-4-yl)urea;SB 265610;1-(2-Bromophenyl)-3-(4-cyano-1H-benzo[d] [1,2,3]triazol-7-yl)urea;Urea, N-(2-bromophenyl)-N'-(4-cyano-1H-benzotriazol-7-yl)-;SB265610 >=98% (HPLC);CXCR,nonpeptide,inhibit,Inhibitor,SB-265610,inflammation,recruitment,Delay,SB 265610,healing,neutrophil,SB265610,wound,CXC chemokine receptors;SB-265610, 10 mM in DMSO | CAS: | 211096-49-0 | MF: | C14H9BrN6O | MW: | 357.16 | EINECS: | | Mol File: | 211096-49-0.mol |  |
GSK-CXCR2 manufacturers
- SB-265610
-
- US $51.00-197.00 / mg
- 2025-04-28
- CAS:211096-49-0
- Min. Order:
- Purity: 97.67%
- Supply Ability: 10g
|
211096-49-0
Recommend Suppliers |
|